SIRT2 and cancer: The top-ranked compounds were docked in the apo form of SIRT-2 [6] (PDB code 1J8F) and four candidates were evaluated in vitro (the best inhibitors, namely, 8c and (R)-8c, showed potent anti-cancer effects, see Section 2.2.1).